FDA Drug Risk Communication Should Include Drug Benefit Info, PhRMA Says
Executive Summary
FDA risk communication materials should include information about a drug's benefits to avoid scaring patients away from their medications, the Pharmaceutical Research & Manufacturers of America said
You may also be interested in...
FDA Poised To Overhaul Distribution Of Consumer Medical Information
FDA appears poised to begin an overhaul of the dissemination of consumer drug information
FDA Poised To Overhaul Distribution Of Consumer Medical Information
FDA appears poised to begin an overhaul of the dissemination of consumer drug information
FDA’s Internal Research Activities Will Get Broad Review By Science Board
FDA's Science Board is conducting a strategic review of agency research projects as part of an effort to reduce duplication and identify deficient areas